Trial
NCT06267872
A Clinical Trial in Adult Participants Without HIV and in Overall Good Health to Evaluate the Safety and Immunogenicity of CD4BS CH505M5 Pr-NP1 Followed by CH505 TF chTrimer Boost Both Adjuvanted With Either Lipid Nanoparticles (LNPs) or 3M-052-AF + Alum
Phase IWITHDRAWNSAFETYConfidence: HIGH
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
National Institutes of Health (NIH); Department of Health and Human Services; Duke University; Access to Advanced Health Institute (AAHI)
Condition
HIV
Intervention
CD4BS CH505M5 Pr-NP1
Why stopped
FDA Clinical Hold
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-26